The “Borne Mission” Report analysis: Between hope and disappointment for the pharmaceutical industries

Borne’s long-awaited Report on regulation of healthcare products has fallen well short of pharmaceutical industry expectations. Indeed, it contains very few concrete proposals….
By: Hogan Lovells
Previous Story

Firms Announce New Crypto Initiatives; Court Overturns Bitcoin ETF Rejection; FASB Updates Crypto Accounting Standard; SEC Brings NFT Enforcement Action

Next Story

FY24 National Defense Authorization Act Provisions Aim to Increase Artificial Intelligence Research, Development, and Contracting Opportunities